551 related articles for article (PubMed ID: 24436096)
21. S100A8/A9 increases the mobilization of pro-inflammatory Ly6C
Cremers NAJ; van den Bosch MHJ; van Dalen S; Di Ceglie I; Ascone G; van de Loo F; Koenders M; van der Kraan P; Sloetjes A; Vogl T; Roth J; Geven EJW; Blom AB; van Lent PLEM
Arthritis Res Ther; 2017 Sep; 19(1):217. PubMed ID: 28969686
[TBL] [Abstract][Full Text] [Related]
22. S100A8/A9 is not essential for the development of inflammation and joint pathology in interleukin-1 receptor antagonist knockout mice.
Di Ceglie I; van Lent PLEM; Geven EJW; Koenders MI; Blom AB; Vogl T; Roth J; van den Bosch MHJ
Arthritis Res Ther; 2021 Aug; 23(1):216. PubMed ID: 34412663
[TBL] [Abstract][Full Text] [Related]
23. Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9.
De Ponti A; Wiechert L; Stojanovic A; Longerich T; Marhenke S; Hogg N; Vogel A; Cerwenka A; Schirmacher P; Hess J; Angel P
Int J Cancer; 2015 May; 136(10):2458-63. PubMed ID: 25331529
[TBL] [Abstract][Full Text] [Related]
24. S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes.
Nukui T; Ehama R; Sakaguchi M; Sonegawa H; Katagiri C; Hibino T; Huh NH
J Cell Biochem; 2008 May; 104(2):453-64. PubMed ID: 18044712
[TBL] [Abstract][Full Text] [Related]
25. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
26. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
[TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
[TBL] [Abstract][Full Text] [Related]
28. S100A8 and S100A9 in Cancer.
Chen Y; Ouyang Y; Li Z; Wang X; Ma J
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
[TBL] [Abstract][Full Text] [Related]
29. DAMP molecules S100A9 and S100A8 activated by IL-17A and house-dust mites are increased in atopic dermatitis.
Jin S; Park CO; Shin JU; Noh JY; Lee YS; Lee NR; Kim HR; Noh S; Lee Y; Lee JH; Lee KH
Exp Dermatol; 2014 Dec; 23(12):938-41. PubMed ID: 25308296
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
Marinković G; Grauen Larsen H; Yndigegn T; Szabo IA; Mares RG; de Camp L; Weiland M; Tomas L; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Eur Heart J; 2019 Aug; 40(32):2713-2723. PubMed ID: 31292614
[TBL] [Abstract][Full Text] [Related]
31. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion.
Ryckman C; Vandal K; Rouleau P; Talbot M; Tessier PA
J Immunol; 2003 Mar; 170(6):3233-42. PubMed ID: 12626582
[TBL] [Abstract][Full Text] [Related]
32. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
[TBL] [Abstract][Full Text] [Related]
33. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
34. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis.
van Lent PL; Blom AB; Schelbergen RF; Slöetjes A; Lafeber FP; Lems WF; Cats H; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2012 May; 64(5):1466-76. PubMed ID: 22143922
[TBL] [Abstract][Full Text] [Related]
35. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
[TBL] [Abstract][Full Text] [Related]
36. S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells.
Eue I; König S; Pior J; Sorg C
Int Immunol; 2002 Mar; 14(3):287-97. PubMed ID: 11867565
[TBL] [Abstract][Full Text] [Related]
37. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
[TBL] [Abstract][Full Text] [Related]
38. Deletion of
Defrêne J; Berrazouane S; Esparza N; Pagé N; Côté MF; Gobeil S; Aoudjit F; Tessier PA
J Immunol; 2021 Feb; 206(3):505-514. PubMed ID: 33361205
[TBL] [Abstract][Full Text] [Related]
39. Localization of S100A8 and S100A9 expressing neutrophils to spinal cord during peripheral tissue inflammation.
Mitchell K; Yang HY; Tessier PA; Muhly WT; Swaim WD; Szalayova I; Keller JM; Mezey E; Iadarola MJ
Pain; 2008 Jan; 134(1-2):216-31. PubMed ID: 18063312
[TBL] [Abstract][Full Text] [Related]
40. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
